Detalhe da pesquisa
1.
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells.
Stem Cells
; 35(4): 1065-1079, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27800660
2.
Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience.
Pediatr Transplant
; 21(3)2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28160352
3.
Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
Biol Blood Marrow Transplant
; 22(10): 1792-1800, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377901
4.
Cord-blood engraftment with ex vivo mesenchymal-cell coculture.
N Engl J Med
; 367(24): 2305-15, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23234514
5.
Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children.
Pediatr Crit Care Med
; 16(3): 245-55, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25581630
6.
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
Biol Blood Marrow Transplant
; 18(4): 584-92, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21867666
7.
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.
Biol Blood Marrow Transplant
; 18(11): 1677-86, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22643322
8.
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Biol Blood Marrow Transplant
; 17(6): 893-900, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20946966
9.
Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
Clin Cancer Res
; 13(15 Pt 1): 4503-10, 2007 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17671136
10.
Cell therapies for traumatic brain injury.
Neurosurg Focus
; 24(3-4): E18, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18341394
11.
Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells.
Mol Cancer Ther
; 6(5): 1610-9, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17513610
12.
Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005.
Medicine (Baltimore)
; 86(6): 324-333, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18004177
13.
Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
Mol Cancer Res
; 3(12): 685-91, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16380506
14.
Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases.
Clin Cancer Res
; 9(9): 3462-8, 2003 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12960138
15.
Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
Clin Cancer Res
; 10(23): 8114-9, 2004 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15585647
16.
Exploring the Cancer Experiences of Young Adults in the Context of Stem Cell Transplantation.
Cancer Nurs
; 38(4): 260-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25232959
17.
Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector.
Cancer Gene Ther
; 9(3): 260-6, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11896442
18.
Fas expression inversely correlates with metastatic potential in osteosarcoma cells.
Oncol Rep
; 9(4): 823-7, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12066216
19.
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.
Clin Lymphoma Myeloma Leuk
; 14(1): e1-5, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24169268
20.
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.
Clin Lymphoma Myeloma Leuk
; 13(3): 296-301, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313065